The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

The CDC's updated guidelines are intended to keep more ... Ask your healthcare provider about pneumococcal vaccination today. For more information about pneumococcal pneumonia risk factors ...

Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has reported positive trial results in children that will ramp up the pressure on Pfizer and ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal ... for health officials to base recommendations for the use of PPV23 ...

Results from a retrospective case-control study indicate that the pneumococcal vaccine provides significant protection in all HIV-infected patients, not just those with CD4 counts ≥200 cells/mm 3.